EUVIMEDEUVIMED entdecken
Studienprotokoll

Impact of a kidney-sparing protocol for the treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections (CLOXECO): a quasi-experimental study

Philippine Babin, Agathe Delbove, Marie Gousseff, Jean-Baptiste Gouin, Yoann Crabol, Mauriac Akoha, Anne Cady, Florian Lemaitre iD, Pierre Tattevin iD, Hugoline Boulay

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf062 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Philippine Babin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Service de néphrologie, Hôpital Pontchaillou, rue le Guilloux, CHU Rennes, France. Hauptthemen laut MEDLINE: Staphylococcal Infections, Anti-Bacterial Agents, Bacteremia, Cefazolin. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antistaphylococcal penicillin (ASP) is the first-line therapy for MSSA bloodstream infection (BSI), with cefazolin as an alternative. However, ASPs are associated with a high risk of acute kidney injury (AKI) and overexposure. We implemented a kidney-sparing protocol based on: (i) systematic use of cefazolin in patients with creatinine clearance of <60 mL/min or any risk factor for AKI; and (ii) reduced ASP dose (75–100 mg/kg/day) with therapeutic drug monitoring.

Methods

We compared all episodes of MSSA BSI in adults admitted during the 15 months before (control period) and the 12 months after (optimization period) protocol implementation. Primary outcome was sterile blood cultures by Day 3. Secondary outcomes included AKI, dialysis, MSSA BSI relapses, and mortality.

Results

We included 100 patients in the control group and 104 in the optimization group. Baseline characteristics were similar in both groups, with a mean ± SD age of 73 ± 20 years, male predominance (73%), and high prevalence of chronic kidney disease (80%) and diabetes (31%). Initial treatment was ASP (cloxacillin) in 80/100 (80%) patients in the control group, versus 24/104 (23%) in the optimization group (P < 0.001). Day 3 sterile blood cultures, and Day 30 mortality remained similar (respectively 95% versus 93%, and 21% versus 24%; not significant). AKI and dialysis requirements were less frequent during the optimization period, respectively 37% versus 56% (P = 0.045), and 1% versus 8% (P = 0.017).

Conclusions

A kidney-sparing protocol for MSSA BSI based on systematic use of cefazolin in patients with AKI risk factor, and lower ASP doses, was associated with similar efficacy and lower risk of AKI and dialysis requirements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcal InfectionsAnti-Bacterial AgentsBacteremiaCefazolinAcute Kidney InjuryStaphylococcus aureusHumansMaleFemaleAgedMiddle AgedAged, 80 and overTreatment Outcome

Substanzen

Anti-Bacterial AgentsCefazolin

Autor:innen und Institutionen

  • Service de néphrologie, Hôpital Pontchaillou, rue le Guilloux, CHU Rennes, France.
  • Service de réanimation médicale, Centre Hospitalier Bretagne Atlantique, Boulevard Général Maurice Guillaudot, Vannes, France.
  • Service de maladies infectieuses et médecine interne, Centre Hospitalier Bretagne Atlantique, Boulevard Général Maurice Guillaudot, Vannes, France.
  • Service de néphrologie, Centre Hospitalier Bretagne Atlantique, Boulevard Général Maurice Guillaudot, Vannes, France.
  • Service de biologie médicale, Centre Hospitalier Bretagne Atlantique, Boulevard Général Maurice Guillaudot, Vannes, France.
  • Pharmacologie Clinique, Hôpital Pontchaillou, rue le Guilloux, CHU Rennes, France.

ORCID-Profile: Florian Lemaitre, Pierre Tattevin

Zitieren

APA

Babin, P., Delbove, A., Gousseff, M., Gouin, J. B., Crabol, Y., Akoha, M., Cady, A., Lemaitre, F., Tattevin, P., & Boulay, H. (2025). Impact of a kidney-sparing protocol for the treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections (CLOXECO): a quasi-experimental study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf062

Vancouver

Babin P, Delbove A, Gousseff M, Gouin JB, Crabol Y, Akoha M, et al. Impact of a kidney-sparing protocol for the treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections (CLOXECO): a quasi-experimental study. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf062

BibTeX
@article{Babin2025,
  author = {Babin, Philippine and Delbove, Agathe and Gousseff, Marie and Gouin, Jean-Baptiste and Crabol, Yoann and Akoha, Mauriac and Cady, Anne and Lemaitre, Florian and Tattevin, Pierre and Boulay, Hugoline},
  title = {Impact of a kidney-sparing protocol for the treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections (CLOXECO): a quasi-experimental study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf062}
}
Kostenlos starten →